Selected Balance Sheet Information

3 Months Ended

Mar. 31, 2024

Selected Balance Sheet Information

Selected Balance Sheet Information

7. Selected Balance Sheet Information

Prepaid expenses and other current assets (in thousands)

	March 31,		December 31,
	2024		2023
Prepaid manufacturing expenses	$	508	$	491
Prepaid clinical research organizations		364		1,119
Prepaid insurance		337		496
Prepaid consulting, subscriptions and other expenses		278		180
VAT receivable		136		128
Total	$	1,623	$	2,414

Prepaid clinical research organizations (CROs) expense is classified as a current asset. The Company makes payments to the CROs based on agreed upon terms that include payments in advance of study services.

7. Selected Balance Sheet Information – (continued)

Property and equipment, net (in thousands)

	March 31,		December 31,
	2024		2023
Computers and office equipment	$	900	$	902
Other property, plant and equipment		407		417
Leasehold improvements		94		94
Software		11		11
		1,412		1,424
Less: accumulated depreciation and amortization		(1,037)		(1,002)
Total	$	375	$	422

Accrued expenses (in thousands)

	March 31,		December 31,
	2024		2023
Accrued clinical consulting services	$	2,424	$	1,700
Accrued manufacturing costs		593		843
Accrued vendor payments		310		452
Total	$	3,327	$	2,995

Accrued employee benefits (in thousands)

	March 31,		December 31,
	2024		2023
Accrued bonus expense	$	325	$	1,307
Accrued compensation expense		224		127
Accrued vacation expense		115		83
Total	$	665	$	1,517